In addition, 67 cases missense mutation, 4 cases truncating mutation, and 2 cases splice mutation was identified in 10976 samples of TCGA pan-cancer analysis and post-transcription modifications of STC2 including phosphorylation, ubiquitination, O-linked glycosylation was characterized through Cbioportal database (Figure 2C). The gene discussed is STC2; the disease is cancer.